Biomarkers for assessment of intestinal permeability in clinical practice

2021/05/19 by Benjamin Seethaler, Maryam Basrai, Audrey M. Neyrinck +5 · 2 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Drug Transport and Resistance Mechanisms #Gut microbiota and health #Iron Metabolism and Disorders

paper · doi:10.1152/ajpgi.00113.2021

openalex publication_date 2021/05/19 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31

Abstract

This study shows that biomarkers from blood and fecal samples are associated with the cumbersome established tests of intestinal permeability throughout different cohorts. Therefore, such biomarkers could be used to assess gut barrier function in prospective cohort studies and large-scale clinical trials for which tracer-based tests may not be feasible.

Citations

• Adaptive linear step-up procedures that control the false discovery rate

Cited by

• Inhibition of the metalloprotease ADAM19 as a novel senomorphic strategy to ameliorate gut permeability and senescence markers by modulating senescence-associated secretory phenotype (SASP)
• The effect of probiotic supplementation on zonulin levels in healthy individuals – A systematic review and meta-analysis

Related

• Effects of dietary components on intestinal permeability in health and disease
• Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review
• Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development
• Intestinal permeability in type 1 diabetes: An updated comprehensive overview
• Permeability Benchmarking: Guidelines for Comparing in Silico, in Vitro, and in Vivo Measurements